Figure 2.
Progression-free survival (PFS) according to tumor mutation burden (TMB) in HER2-positive metastatic breast cancer in palliative first-line chemotherapy (A) and palliative second-line chemotherapy (B).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.